Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67dd1f39f37bac4617e37d6d5c60aa8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2008-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_172a147a2a4e892f95c364fd414412e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72c8adcd6429f6afeee00f212fb8b367 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0467f52438664fcceb2ada43ce9a7bc3 |
publicationDate |
2009-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2078717-A1 |
titleOfInvention |
6-Pyrimidinyl-pyrimid-2-one derivative |
abstract |
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof:n nwhich is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2423207-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8569294-B2 |
priorityDate |
2008-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |